Work

Surgical outcomes of primary prolene intraluminal ripcord use in Preserflo MicroShunt surgery in patients at high risk for hypotony

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/aims To assess real-world outcomes of Preserflo MicroShunt (PMS) implantation combined with primary intraluminal ripcord (stent) insertion using a 9–0 polypropylene suture. Methods A consecutive retrospective cohort study including all adult patients undergoing PMS implantation with primary intraluminal stenting at a single centre between September 2021 and May 2024. Participants were followed for a minimum of 6 months and up to 18 months postoperatively. Results Thirty-eight eyes of 35 patients were analysed. The overall surgical success rate at 6 months was 89.5% (complete success 81.6%; qualified success 7.9%). Mean intraocular pressure (IOP) decreased significantly from baseline at all visits, with mean percentage reductions of 40.1%, 34.1% and 30% at 6, 12 and 18 months, respectively (all p<0.001). Glaucoma medication use also decreased significantly at all timepoints (all p<0.001), averaging 0.12±0.48 medications at 6 months. Intraluminal stents were removed in 63.2% of eyes at a median of 84 days post-surgery (IQR 35–124). Numerical hypotony (IOP <6 mm Hg without visual or anatomical sequelae) occurred in six eyes (15.8%), all resolving with conservative management. Conclusions Primary intraluminal stenting with a 9–0 prolene suture effectively prevented clinically significant hypotony while maintaining stable IOP and reduced medication dependence at 6 months. These outcomes remained stable in the subset of patients followed for up to 18 months after PMS implantation.
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7233842926
FWCI:
Cites: 20
Cited by:
Related to: 10